A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13104-015-1214-9
Published Online: 2015-06-05
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Minemura, Hiroyuki
Yokouchi, Hiroshi
Azuma, Keisuke
Hirai, Ken-ichiro
Sekine, Satoko
Oshima, Kengo
Kanazawa, Kenya
Tanino, Yoshinori
Inokoshi, Yayoi
Ishii, Taeko
Katsuura, Yutaka
Oishi, Akio
Ishida, Takashi
Munakata, Mitsuru